Sundar Selvaraj/NBDF LinkedIn
Sep 26, 2025, 10:44
Sundar Selvaraj – A Scientist Advancing Hemophilia A Research While Living with Severe FXIII Deficiency and VWD 2M
National Bleeding Disorders Foundation (NBDF) shared on LinkedIn:
”Researcher. Advocate. Dad.
Sundar Selvaraj brings a unique dual perspective to the LEE Research Advisory Council, as a scientist studying hemophilia A and as someone living with both severe factor XIII deficiency and type 2M von Willebrand disease.
Based in Michigan, he’s committed to advancing biomedical research while ensuring patient voices stay at the center.
Learn more about Sundar.”
More winner stories featured in Hemostasis Today.
-
Oct 9, 2026, 10:40What New U.S. Data Reveal About GT – Glanzmann’s Research Foundation
-
Oct 9, 2026, 10:32Anjali Pandey: The Morphologic Clues to MDS With del(5q)
-
Oct 9, 2026, 10:13Reza Shojaei: 5 Leadership Responsibilities for a Sustainable Plasma Ecosystem
-
Oct 9, 2026, 08:38Johannes Gratz: Perioperative Care in Factor VII Deficiency – Treating the Patient, Not the Number
-
Oct 9, 2026, 08:28Ghanim Fajish: Vascular Cells May Retain a Prothrombotic Memory of Oxidative Stress
-
Oct 9, 2026, 07:43Mehmet Cilingiroglu: The First Diagnosis of Coronary Thrombosis in a Living Patient
-
Oct 9, 2026, 07:21Federico Ravaioli: 40 kPa Spleen Stiffness May Help Avoid Endoscopy in Chronic PVT
-
Oct 9, 2026, 07:00Danny Reardon: Closing the Global Awareness Gap on Blood Clots
-
Oct 9, 2026, 00:54Mary Catherine Moffett: Advancing Advocacy Together – Highlights from the Sanofi Bleeding Disorders Summit